Pengkai Ma
Beijing University of Chinese Medicine(CN)
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics, Cancer, Hypoxia, and Metabolism, Hepatocellular Carcinoma Treatment and Prognosis, RNA Interference and Gene Delivery
Most-Cited Works
- → Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release(2018)79 cited
- → Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab(2015)44 cited
- → Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy(2021)40 cited
- → Glucose transporter 1 (GLUT1)-targeting and hypoxia-activated mitochondria-specific chemo-thermal therapy via a glycosylated poly(amido amine)/celastrol (PAMAM/Cel) complex(2021)32 cited
- → Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate(2017)32 cited
- → Pharmacokinetics, metabolism, and excretion of cycloastragenol, a potent telomerase activator in rats(2016)27 cited
- → Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate(2016)27 cited
- → Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere(2020)18 cited
- → GLUT1 targeting and hypoxia-activating polymer-drug conjugate-based micelle for tumor chemo-thermal therapy(2021)16 cited
- → Simultaneous determination of six coptis alkaloids in urine and feces by LC–MS/MS and its application to excretion kinetics and the compatibility mechanism of Jiao‐Tai‐Wan in insomniac rats(2018)16 cited